Pulse Biosciences Newsroom

Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Largest Shareholder, Top Key Executive Robert Duggan Sees Holdings Value Fall by 4.8% Following Recent Drop

Simply Wall StNov 15 20:04

12 Health Care Stocks Moving In Friday's Intraday Session

BenzingaNov 2 00:36

Pulse Biosciences New Treatment Study Shows Reduction of Benign Thyroid Nodules

MT NewswiresNov 1 03:24

Pulse Biosciences Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q3 EPS Results.

BenzingaNov 1 02:51

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association

BusinesswireNov 1 02:25

Q3 2024 Pulse Biosciences Inc Earnings Call

Yahoo FinanceNov 1 01:58

Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript Summary

Futu NewsOct 31 10:05 · Conference Call

Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsOct 31 09:42

Pulse Biosciences | 10-Q: Q3 2024 Earnings Report

SECOct 31 04:12 · Announcements

Express News | Pulse Biosciences Q3 Income From Operations USD -13.655 Million

BreakingsOct 31 04:05

Pulse Biosciences 3Q Loss $12.7M >PLSE

Dow JonesOct 31 04:05

Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology

BusinesswireOct 31 04:02

Express News | Pulse Biosciences Announces Appointment of David Kenigsberg, M.d. as Chief Medical Officer of Electrophysiology

BreakingsOct 31 04:02

Pulse Biosciences (PLSE.US) will release its financial report after the market closes on October 30th.

$Pulse Biosciences (PLSE.US)$ will release its financial report after the market closes on October 30. How was its previous performance? In 2024 Q2, revenue was $0.0, net income was -$-11.383 million, and EPS was -$0.2. In 2023 Q3, revenue was $0.0, net income was -$-10.566 million, and EPS was -$0.186832. The above data is based on US GAAP accounting standards. Reminder from Futubull.

Futu NewsOct 25 09:00

Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024

BusinesswireOct 21 20:00

Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris Therapeutics, Alma Lasers, BIOLASE, BioLineRx, DermBiont, Novartis and Pulse Biosciences

Yahoo FinanceAug 28 16:06

Pulse Biosciences | 10-Q: Q2 2024 Earnings Report

SECAug 20 04:28 · Announcements

Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday

BenzingaAug 13 23:44

Earnings Call: Pulse Biosciences Details Progress on Nano-PFA Devices

InvestingAug 13 17:22

Earnings Call Summary | Pulse Biosciences(PLSE.US) Q2 2024 Earnings Conference

Futu NewsAug 13 07:55 · Conference Call